Table 2 Baseline characteristic of the patients in the FAS
Placebo | Dexamethasone | Total | |
|---|---|---|---|
N = 19 | N = 19 | N = 38 | |
Gender | |||
male | 10 (52.6%) | 11 (57.9%) | 21 (55.3%) |
female | 9 (47.4%) | 8 (42.1%) | 17 (44.7%) |
Age | |||
Mean +/− SD | 58.6 +/− 15.0 | 61.6 +/− 12.1 | 60.1 +/− 13.6 |
Focal neurological signs | |||
yes | 12 (63.2%) | 15 (78.9%) | 27 (71.1%) |
Seizures within last 5 days | |||
yes | 11 (57.9) | 11 (57.9%) | 22 (57.9%) |
Result of PCR | |||
positive | 19 (100.0%) | 19 (100.0%) | 38 (100.0%) |